Cargando…

A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score

PURPOSE: This study aims to establish and validate a new diagnosis model called P.Z.A. score for clinically significant prostate cancer (csPCa). METHODS: The demographic and clinical characteristics of 956 patients were recorded. Age, prostate-specific antigen (PSA), free/total PSA (f/tPSA), PSA den...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zongxin, Zhang, Jun, Jin, Di, Wei, Xuedong, Qiu, Feng, Wang, Ximing, Zhao, Xiaojun, Pu, Jinxian, Hou, Jianquan, Huang, Yuhua, Huang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668430/ https://www.ncbi.nlm.nih.gov/pubmed/37996859 http://dx.doi.org/10.1186/s12885-023-11306-2

Ejemplares similares

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
por: Huang, Chen, et al.
Publicado: (2022)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

Multiparametric MRI in the PSA Screening Era
por: George, Arvin K., et al.
Publicado: (2014)

Direct Determination of Pyrazinamide (PZA) Susceptibility by Sputum Microscopic Observation Drug Susceptibility (MODS) Culture at Neutral pH: the MODS-PZA Assay
por: Alcántara, Roberto, et al.
Publicado: (2020)

Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
por: Venkatesan, Aradhana M., et al.
Publicado: (2021)

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?
por: Abd-Alazeez, Mohamed, et al.
Publicado: (2014)

Ability of the MeltPro MTB/PZA Assay to Detect Susceptibility to Pyrazinamide in Rifampin-Resistant Tuberculosis Patients
por: Li, Rong, et al.
Publicado: (2023)

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer
por: Fütterer, Jurgen J.
Publicado: (2017)

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA
por: Müller, Stig, et al.
Publicado: (2018)

MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins
por: He, Dong, et al.
Publicado: (2021)

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision
por: Lin, Yuxin, et al.
Publicado: (2020)

Prognostic significance of sarcopenia and systemic inflammation for patients with renal cell carcinoma following nephrectomy
por: Liu, Qiuchen, et al.
Publicado: (2022)

Activity of Pyrazinamide against Mycobacterium tuberculosis at Neutral pH in PZA-S1 Minimal Medium
por: Shi, Wanliang
Publicado: (2021)

Clinical significance of multiparametric MRI and PSA density as predictors of residual tumor (pT0) following radical prostatectomy for T1a-T1b (incidental) prostate cancer
por: Chung, Doo Yong, et al.
Publicado: (2018)

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China
por: Li, Kun, et al.
Publicado: (2021)

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
por: Wallström, Jonas, et al.
Publicado: (2021)

Development and validation of a nomogram for predicting the overall survival of prostate cancer patients: a large population-based cohort study
por: Zhou, Zheng, et al.
Publicado: (2022)

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
por: Pye, Hayley, et al.
Publicado: (2021)

Multiparametric MRI in Prostate Cancer
por: Esen, Tarık, et al.
Publicado: (2014)

Comparison of Multiparametric and Biparametric MRI in First Round Cognitive Targeted Prostate Biopsy in Patients with PSA Levels under 10 ng/mL
por: Lee, Dong Hoon, et al.
Publicado: (2017)

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Carbunaru, Samuel, et al.
Publicado: (2021)

Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
por: Mo, Li-Cai, et al.
Publicado: (2022)

B7-H3 promoted proliferation of mouse spermatogonial stem cells via the PI3K signaling pathway
por: Wei, Xuedong, et al.
Publicado: (2017)

The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol
por: Millard, James D., et al.
Publicado: (2019)

Multiparametric-MRI in diagnosis of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2015)

Expression and clinical significance of interleukin-9 in renal tumors
por: Zhang, Zhiyu, et al.
Publicado: (2020)

Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?
por: Grey, Alistair D. R., et al.
Publicado: (2020)

Prostatic Leiomyoma – Multiparametric Prostate MRI Features
por: Vergauwen, Ortwin, et al.
Publicado: (2018)

MRI multiparametric scoring system for pial blood supply of intracranial meningiomas
por: Higaki, Fumiyo, et al.
Publicado: (2022)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Multiparametric transrectal ultrasound for the diagnosis of peripheral zone prostate cancer and clinically significant prostate cancer: novel scoring systems
por: Chen, Tong, et al.
Publicado: (2022)

Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50
por: Gielchinsky, Ilan, et al.
Publicado: (2018)

Integrating multiparametric prostate MRI into clinical practice
por: Padhani, A.R.
Publicado: (2011)

Multiparametric MRI of the prostate: the hope for the urology community
por: Kozikowski, Mieszko, et al.
Publicado: (2016)

Repeatability of Multiparametric Prostate MRI Radiomics Features
por: Schwier, Michael, et al.
Publicado: (2019)

Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system
por: Alqahtani, Saeed, et al.
Publicado: (2020)

Evaluation of PCA3 and multiparametric MRI’s: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL
por: Okcelik, Sezgin, et al.
Publicado: (2016)

Resection of adult polycystic kidney with retroperitoneal laparoscopic technique assisted by arterial embolization
por: Li, Feng, et al.
Publicado: (2020)

Advanced multiparametric MRI-based scoring for isocitrate dehydrogenase mutation prediction of gliomas
por: Hosur, Bharat, et al.
Publicado: (2022)

Detection of clinically significant prostate cancer with PI-RADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions
por: Westphalen, Antonio C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l754ehbsbao2pn3490um463pkr